Adrian Allbon: Jarden's director of equity research on A2 Milk getting approval to sell infant formula in the US

A2 Milk has finally got the all clear to sell its infant formula in the U.S. It applied for the approval back in May when America announced a nationwide shortage, and finally got to break into the market this month. Adrian Allbon, Jarden's director of equity research, considers this a positive development. The approval process only lasts til January currently, but A2 Milk has an opening to extend their approval and expand their brand into a US market.  LISTEN ABOVE  See omnystudio.com/listener for privacy information.